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CONTINUING EDUCATION 
Immunology and management of sepsis 
W A. Lynn andJonathan Cohen 
Department of Infectious Diseases and Bacteriology, Hammersmith Hospital, London 
Readers are invited to use this article as a seZf-assessment 
exercise and to update their knowledge 
ILLUSTRATIVE CASE HISTORIES 
Case 1 
A 27-year-old male schoolteacher presented at 11 PM 
as an emergency to the casualty department. According 
to the history taken from his wife, he had been 
completely well that morning but had returned home 
early fiom work thinking that he had influenza. He had 
complained of aches in his muscles and feeling shivery. 
He had gone to bed and at 8 PM he had told his wife 
that he was feeling a little better. At 10 PM she found 
him rambling and incoherent and called a doctor. On 
examination he was pyrexial (39.5"C, pulse 125 beats/ 
min, BP 90/60) and there was a faint macular rash on 
the extremities that blanched on pressure. His conscious 
level was reduced but there was no neck stiffness 
and there were no focal neurologic signs. Meningococcal 
infection was suspected and 4 million units of penicdlin 
were administered intravenously. Investigations revealed 
the following: Hb 13.4 g/dL, WBC 3.2 x 109/L, 
platelets 54 X 10l2/L, Na 143 mmol/L, K 3.6 mmol/L, 
urea 9.0 mmol/L, HCOT 21 mmol/L. Chest radio- 
graphy and cranial computed tomography (CT) were 
normal, and a lumbar puncture performed after the CT 
scan was also normal, with no inflammatory cells and 
negative Gram stain. Cerebrospinal fluid culture was 
sterile but blood cultures taken on adrmssion sub- 
sequently grew Neisseria meningitidis type B. 
The patient was adrmtted to intensive care and over 
the next 8 h his condition steady deteriorated, with 
the development of severe hypotension requiring 
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inotropic/pressor support, oliguria, a widespread 
purpuric rash, evidence of msseminated intravascular 
coagulation and progressive hypoxemia such that he 
required elective intubation and ventilation. His 
condition then began to stabilize but he required 
ventilation for a total of 14 days, and temporary 
hemodialysis for acute renal failure, and suffered 
ischemic necrosis of two fingers on his left hand and 
several toes. He eventually left hospital 6 weeks after 
the initial admission and was able to return to work 3 
months later. 
Case 2 
A 54-year-old female presented with fever and breath- 
lessness and was found to have tuberculous pericarditis. 
She was treated with antituberculous therapy plus 
60 mg of prednisolone daily. Despite this, she 
developed progressive cardiac failure, and 3 weeks later 
underwent an uncomplicated pericardectomy. Two 
days after leaving intensive care she became hypotensive 
on the general ward. She was transferred back to 
intensive care and examination revealed the following: 
temperature 37.2"C, pulse 100 beatdmin, BP 60140, 
respirations 32/min. Her sternotomy wound was clean 
and not inflamed, there was dullness and there were 
coarse crackles at the left base, on cardiovascular 
examination there was a soft pericardial rub, and she 
was disorientated but with no focal neurologic signs. 
Arterial blood gases on air were as follows: pH 7.48, 
PC02 2.7 kPa, PO2 9.8 kPa, HCOY 19 mmol/L, base 
excess -6. Chest X-ray showed some atelectasis and a 
small pleural effusion at the left base. Cardiac 
tamponade or pulmonary embolism were thought the 
most likely diagnoses, and urgent echocardiography 
and right heart catheterization were performed. Echo- 
cardiogram showed no tamponade and her right heart 
catheter revealed the following: central venous pressure 
(CVP) +1 cm, cardiac output (CO) 8 L/min, systemic 
vascular resistance (SVR) 400 dyne/s per cm5 (normal 
800-1200). The low SVR raised the possibility of 
underlying sepsis and the patient was treated with 
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intravenous fluids, oxygen, pressor agents and intra- 
venous cefotaxime plus flucloxacdhn. Blood and urine 
both grew Escherichia coli resistant to ampicillin and 
sensitive to cefotaxime. The patient made a rapid and 
complete recovery. 
COMMENTS ON CASE REPORTS 
These two cases were chosen to highlight hfferent 
aspects of the clinical presentation of sepsis. In the first 
case a completely well individual was struck down by 
infection with a highly virulent organism. There was 
no doubt over the diagnosis at presentation but despite 
prompt antimicrobial therapy and supportive intensive 
care the patient’s condition progressed within hours, 
with the development of multi-organ failure from 
whch he was lucky to survive. In the second case the 
infection was acquired in hospital while the patient was 
being treated for another condition. Ths patient was 
immunocompromised from corticosteroid therapy and 
had undergone urinary catheterization after cardio- 
thoracic surgery, both of which are risk factors for 
infection. Prompt recognition and therapy prevented 
progression to multi-organ failure. The presentation 
was obscure and highhghts the fact that sepsis should 
always be considered in the differential diagnosis of 
hypotension even, as in this case, if the patient is 
apyrexial. 
MULTIPLE-CHOICE QUESTIONS 
Clinical and immunologic aspects of sapsis 
In each ofthe numbered questions at least one, and up to fouq 
of the individual entries are correct. (The answers are at the 
end of this article). 
1. Etiology and epidemiology of sepsis 
a) Sepsis refers to bloodstream infection 
by pathogenic organisms 
b) Gram-positive bacteria are the 
commonest underlying infection 
c) Most cases are due to community- 
acquired infection 
d) The mortality fiom septic shock 
has improved steadily over the past 
20 years 
e) Patients may display the signs of 
sepsis without any infection 
2. The following clinical features 
a) Diarrhea 
b) Conhsion 
c) Hypothermia 
suggest underlying sepsis 
True/False 
True/False 
True/False 
True/False 
True/False 
True/False 
True/False 
True/False 
Ecthyma gangrenosum is suggestive 
of Staphylococcus aweus bacteremia True/False 
Respiratory alkalosis True/False 
Pathophysiologic changes in sepsis 
Pulmonary vascular resistance is typically 
reduced True/False 
Cardiac index may be elevated or 
suppressed True/False 
Ketoacidosis is a common 
complication True/False 
Hypoglycemia may occur True/False 
Tissue oxygen extraction is increased True/False 
In the pathogenesis of sepsis 
Activation of tissue factor promotes 
a procoagulant state TrueIFalse 
Interleukin-10 may protect against 
sepsis True/False 
Neutropenia predsposes to septic 
shock True/False 
Decreased nitric oxide production 
leads to vasoddatation True/False 
Bacterial translocation from the gut 
may occur True/False 
The following are true of endo- 
toxin (lipopolysaccharide, LPS) 
Endotoxin is an integral component of 
the Gram-positive bacterial cell wall 
Lipid A is the bioactive subunit of 
endotoxin responsible for triggering 
sepsis True / False 
In experimental animals antibodies 
directed against the outer poly- 
saccharide moiety of endotoxin protect 
against challenge with heterologous 
Gram-negative bacteria True/False 
CD 14 mediates endothelial responses 
to endotoxin True/False 
Lipopolysaccharide-binding protein 
(LBP) neutralizes endotoxin True/False 
True/False 
Tumor necrosis factor (TNFa) 
Causes myocardial depression True/False 
Decreases neutrophd adherence to 
endothelium True/False 
Can be augmented in its effects by 
circulating forms of the TNF a 
receptor True/False 
Can be detected in the circulation 
of humans afier intravenous challenge 
with endotoxin TrueIFalse 
Induces an anabolic state True /False 
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Staphylococcal toxic shock syndrome 
Is almost always seen in menstruating 
women True/False 
Requires bloodstream invasion and 
dissemination of staphylococci True/False 
Toxic shock syndrome toxin-1 is a 
superantigen True/False 
Palmar desquamation typically occurs TrudFalse 
Has a higher mortality than Gram- 
negative septic shock True/False 
In the therapy of sepsis 
Antibiotics may liberate free endo- 
toxin from Gram-negative bacteria True/False 
Early antibiotic therapy reduces the 
mortality of meningococcal sepsis TrudFalse 
Corticosteroids are indicated in 
severe sepsis with shock True/False 
Noradrenaline improves renal blood 
flow True/False 
Dobutamine is often used to increase 
the cardiac index True/False 
COMMENTS O N  MULTIPLE-CHOICE QUESTIONS 
Question 1 
There has been much debate over the terminology of 
sepsis during the past decade. Currently accepted 
terminology and definitions were agreed at a consensus 
conference of the Society for Critical Care Medicine 
and the American College of Chest Physicians [l] and 
are as listed in Table 1. Thus bacteremia and sepsis are 
not the same thing, and patients may develop a severe 
systemic response to a localized infection, namely the 
systemic inflammatory response syndrome (SIRS). 
Furthermore, a number of non-infectious inflam- 
matory insults such as pancreatitis, trauma and burns 
can cause SIRS independently of infection. The exact 
prevalence of severe sepsis is not known and wdl vary 
between different patient populations. In recent 
epidemiologic studies the attack rate for SIRS has been 
measured at 13.6/1000 hospital admissions [2]. SIRS 
appears to be responsible for about 10% of adrmssions 
to intensive care [3] but may develop in up to 68% of 
patients whilst in the intensive care unit (ICU) [4]. 
Mortality rates vary from 10-20% for Gram-negative 
bacteremia, to 30-50% in severe sepsis, to over 70% in 
refractory septic shock with multi-organ failure. 
Early epidemiologic studies identified a pre- 
dominance of Gram-negative bacterial infections in 
patients with shock. However, over the past 10 years 
there has been a shift in the microbiology of hospital 
infections towards gram-positive bacteria and in most 
studies Gram-positive bacteria, are now responsible for 
Table 1 Terminology and definitions associated with sepsis 
~~ ~ 
Condition Clinical features 
Bacteremia 
Systemic inflammatory 
response syndrome (SIRS) 
Sepsis 
Severe sepsis 
Septic shock 
Presence of viable bacteria in the 
bloodstream 
Systemic inflammatory response to a 
variety of insults 
Temp. >38*C or <36”C 
Heart rate >90 beats/min 
Resp. rate >20/min or reduced 
WBC >12 or <4 or >lo% ‘bands’ 
Identical to SIRS but as the result of 
infection 
Sepsis associated with organ 
dysfunction, hypoperfusion or 
hypotension 
PaCOz 
Lactic acidosis 
Deterioration in mental state 
Oliguria 
Hypotension 
Systolic <90 mmHg or 
40 mmHg fall from baseline 
not due to any other cause 
Sepsis plus hypotension despite 
adequate fluid resuscitation and 
dependence on pressor agents to 
maintain BP 
Adapted from Bone et al. [l]. 
at least 50% of cases of sepsis [5,6]. Risk factors for 
sepsis include hospitalization, immunosuppression, 
trauma and surgical procedures, and it is not surprising 
that the majority of cases are nosocomially acquired [7]. 
Although prompt recognition and treatment of early 
sepsis may prevent disease progression, once refractory 
shock is established the mortality is at least 50% and has 
not been reduced by current therapies. 
Question 2 
The symptoms of sepsis are non-specific and the 
diagnosis is frequently not made until hypotension 
develops. Diarrhea and/or vomiting are frequently seen 
early in patients with sepsis, and are often dismissed as 
being due to gastroenteritis. Mental confusion may 
occur as a result of hypoxia or acidosis, or as part of a 
‘septic encephalopathy’. In sepsis, increased lactic acid 
production leads to increased respiratory drive. Thus, 
in the early stages the patient is often breathless but with 
normal lungs and a respiratory alkalosis on arterial 
blood gases. As the disease progresses, these com- 
pensatory changes fail and metabolic acidosis with 
increased serum lactate dominates the picture. It is 
important to remember that patients with severe sepsis 
may be hypothermic and that this carries a higher 
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mortality. Ecthyma gangrenosum is a characteristic skin 
lesion with a black necrotic center seen in neutropenic 
sepsis and is most commonly due to Gram-negative 
bacteria, particularly Pseudomonas aeruginosa. 
Question 3 
The key physiologic change in sepsis is a fall in systemic 
vascular resistance with microvascular shunting across 
capillary beds. There is an associated increase in cardiac 
index to compensate for the lowered systemic resistance 
but in severe sepsis the effects of cpokines and acidosis 
may lead to impaired myocardial hnction and so the 
cardiac index may actually be reduced. Reduced arterial 
oxygenation and capillary shunting produces tissue 
hypoxia and anaerobic respiration, adding to lactic 
acidosis. Despite the need of the tissues for oxygen, 
capillary bed shunting means that tissue oxygen 
delivery (and therefore oxygen extraction) is reduced, 
further exacerbating the tissue hypoxia. Although 
systemic vascular resistance is low, the response of 
the pulmonary vascular bed to hypoxia is to constrict, 
leading to elevated pulmonary vascular resistance. 
Question 4 
Severe sepsis and multi-organ failure is the end result of 
a complex interaction of pro-inflammatory and anti- 
inflammatory processes triggered by bacterial products 
such as endotoxin (hpopolysaccharide, LPS). Following 
activation of responsive cells (predominantly macro- 
phages, neutrophils and endothelial cells), numerous 
inflammatory mediators are released, including cyto- 
kines (e.g. TNFa, IL-I), activated complement factors, 
kinins, arachidonate metabolites and platelet-activating 
factor. On  the vascular endothelium, the end result of 
these stimuli is the activation of procoagulant activity, 
whch is one factor contributing to the development of 
disseminated intravascular coagulation. Endothelial 
activation and damage also leads to increased neutrophd 
transmigration into tissues and widespread ‘capillary 
leak’. The migration of activated neutrophils into 
healthy tissues is a key factor in the pathogenesis of 
organ failure [6,8-111, and although bacteremia is a 
common consequence of neutropenia, full-blown 
septic shock is encountered relatively less often in 
neutropenic patients. Anti-inilammatory (or counter- 
regulatory) mediators released in sepsis include IL-4, 
IL-10, IL-13, platelet-derived growth factor-P, IL-1 
receptor antagonist (IL-1Ra) and soluble TNF 
receptors (sTNFR) [9,12]. IL-10 inhibits the release of 
both TNFa and IL-1 and is being investigated as a 
possible therapy for severe sepsis. Nitric oxide (NO) is 
an endogenous vasodilator synthesized in many cell 
types, including vascular smooth muscle and endo- 
thelium. N O  production is increased in sepsis and 
appears to be responsible, at least in part, for the 
widespread vasodilatation that is so characteristic in 
sepsis. Inhibiting NO in sepsis increases SVR and 
blood pressure but at the expense of impahing tissue 
oxygenation and cardiac output. Breakdown of gastro- 
intestinal integrity is common in severe illness, including 
sepsis, and may allow bacteria or bacterial products to 
enter the systemic circulation thus bypassing the liver 
(bacterial translocation). In experimental models this 
may precipitate or exacerbate sepsis but the clinical 
importance of t h s  in humans is not known. 
Question 5 
LPS is one of the best recognized causes of sepsis. LPS 
is found as an integral component of the outer leaflet 
of the cell wall of all Gram-negative bacteria. Lipid A 
is a unique d-glucosamine-based phospholipid that is 
highly conserved across Gram-negative bacteria. Lipid 
A is covalently linked to a relatively conserved core 
oligosaccharide and then to a repeated polysaccharide 
chain (0 antigen) that varies widely between bacterial 
strains. In experimental models synthetic lipid A is 
capable of inducing septic shock. Antibodies directed 
against the inner core of LPS may protect against 
challenge with heterologous bacterial strains, but 
antibodes to the outer 0 antigen only protect against 
that individual strain. Considerable progress has been 
made in understanding the basis of cellular activation 
by LPS. LPS first interacts with a serum protein, 
lipopolysaccharide-bindmg protein (LBP) [ 131. LBP 
acts as ‘shuttle’ presenting LPS to CD14, a glyco- 
sylphosphoinositol-linked protein on the surface of 
neutrophils and macrophages. Endothelial cells do 
not express CD14 but soluble CD14 is found in the 
circulation and appears to be able to mediate endo- 
thelial responses to LPS [14]. The currently favored 
hypothesis is that CD14 is not itselfa signaling receptor 
but mediates the interaction between LPS and an as yet 
unidentified signaling molecule [15,16]. The elucida- 
tion of these events wdl hopefidly lead to specific anti- 
endotoxin therapeutic strategies in the near hture [171. 
Question 6 
TNFa is one of the central inflammatory cytolunes in 
the host response to infection and in the pathogenesis 
of sepsis [18,19]. TNFa is released in vim, by macro- 
phages and neutrophils in response to LPS or products 
h m  Gram-positive bacteria. In human volunteers 
T N F a  appears in the circulation 2 to 4 h after endo- 
toxin challenge [20], and T N F a  can induce all of 
the features of septic shock in experimental animals. 
T N F a  has pleotropic inflammatory actions, includmg 
enhancing neutrophd adherence to endothelium by 
upregulation of both neutrophil and endothelial 
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adherence molecules. After cellular activation TNFa 
receptors are proteolytically cleaved from the cell surface 
and appear in the circulation. These soluble TNFa 
receptors (sTNFR) bind to and neutrahze free TNFa, 
thus acting as an endogenous TNFa  regulatory 
mechanism. Chimeric forms of the sTNFR bound to 
the Fc portion of human IgG effectively neutralize 
TNFa in vitro and are under trial in the treatment 
of severe sepsis. Among other actions, TNFa  induces a 
catabolic state (originally T N F a  was called TNF/ 
cachectin) and also inhibits myocardial contractility [21]. 
Question 7 
Staphylococcal toxic shock syndrome is characterized 
by fever, diarrhea, hypotension, a macular rash which 
later desquamates on the palms and soles, and organ 
failure in the context of infection with a toxin-produc- 
ing strain of Staphylococcus uureus. The staphylococcal 
infection may be generalized, but more commonly is 
focal, usually a wound infection or vaginal colonization 
at the time of menstruation. About 50% of cases are 
menstrually associated, with the remainder evenly 
divided between males and females. Toxic shock 
syndrome toxin-1 (TSST-1) is thought to act as a 
superantigen [22]. Superantigens are able to directly 
activate T-cells by binding to both the MHC I1 
molecule on antigen-presenting cells and the Vp 
subunit of the T-cell receptor. Thus, all T-cells with a 
compatible Vp subunit can be activated, and this can 
be up to 20% of the T-cell population, resulting in 
widespread immune stimulation [23]. Superantigenic 
toxins have also been isolated from other staphylococci 
and some strains of streptococci. The mortality of toxic 
shock is less than lo%, in contrast to the 30-50% 
mortality of Gram-negative septic shock. 
Question 8 
Treatment of Gram-negative bacteria with certain 
antibiotics leads to release of fiee LPS, and in some 
experimental animals this may exacerbate or even 
trigger severe sepsis [24]. In childhood meningitis 
there is evidence that postantibiotic release of LPS may 
increase inflammatory indices in the cerebrospinal 
fluid, but in sepsis it has been ddkult  to prove that this 
is a clinically relevant phenomenon. Therefore, until 
such convincing data are available, antibiotics should be 
chosen for their efficacy against the likely infecting 
pathogens rather than on the theoretical consequences 
of endotoxin release. The cardiac index is impaired in 
many patients with sepsis and may be improved by 
dobutamine. Noradrenaline and other pressor agents 
may be required to increase systemic vascular resistance 
where vital organ function is threatened by hypo- 
tension, but may impair renal perfbsion and precipitate 
renal failure. Therefore, a low SVR needs to be inter- 
preted in the context of the clinical picture, and 
noradrenaline should be used cautiously. Many anti- 
inflammatory strategies have been investigated in sepsis 
or are under evaluation [17]. Corticosteroids protect 
animals from subsequent endotoxin challenge, and after 
some promising human studies corticosteroids were 
used in many centers in all septic patients. However, 
large controlled studies and two meta-analyses have 
failed to show any benefit from corticosteroids and, 
indeed, there is a slightly increased mortality as a result 
of secondary infections [25,26]. Therefore, with the 
exception of the special case of toxemic typhoid fever, 
the routine use of corticosteroids in sepsis cannot be 
supported. 
Answers to the multiple-choice questions 
41: a. False; b. True; c. False; d. False; e. True 
4 2 :  a. True; b. True; c. True; d. False; e. True 
4 3 :  a. False; b. True; c. False; d. True; e. False 
4 4 :  a. True; b. True; c. False; d. False; e. True 
QS: a. False; b. True; c. False; d. True; e. False 
4 6 :  a. True; b. False; c. False; d. True; e. False 
47: a. False; b. False; c. True; d. True; e. False 
48: a. True; b. True; c. False; d. False; e. True 
Fulther reading 
Lynn WA, Cohen J. Adjunctive therapy for septic shock a review 
of experimental approaches to therapy. Clin Infect Dis 1995; 
Lynn WA, Cohen J. Management of septic shock. J Infect 1995; 
Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J 
Med 1993; 328: 1471-7. 
Wenzel Rp, Pinsky MR, Ulevitch L, Young L. Current 
understanding of sepsis. Clin Infect Dis 1996; 22: 407-12. 
Young LS. Sepsis syndrome. In Mandell GL, Dolin R, Bennett 
JE, eds. Principles and practice of infectious diseases. New 
York Churchdl Livingstone, 1995: Chapter 56: 691-705. 
20: 143-58. 
30: 207-12. 
References 
1. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and 
organ failure and guidelines for the use of innovative therapies 
in sepsis. The ACCP/SCCM Consensus Conference Com- 
mittee. Chest 1992; 101: 1644-55. 
2. Kiefe H, Hoepelman AI, Zhou W, et al. The sepsis syndrome 
in a Dutch university hospital. Clinical observations. Arch 
Intern Med 1993; 153: 2241-7. 
3. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk 
factors, and outcome of severe sepsis and septic shock in 
adults. A multicenter prospective study in intensive care 
units. French ICU Group for Severe Sepsis. JAh4A 1995; 
274: 968-74. 
4. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural 
history of the systemic inflammatory response syndrome 
(SIRS). A prospective study. JAh4A 1995; 273: 117-23. 
228 Cl in ica l  M i c r o b i o l o g y  and  In fec t ion ,  Vo lume 2 N u m b e r  3 ,  D e c e m b e r  1996  
5. Marks JD, Marks CB, Luce JM, et al. Plasma tumor necrosis 
factor in patients with septic shock. Mortality rate, incidence 
of adult respiratory &stress syndrome, and effects of methyl- 
prednisolone adrmnistration. Am Rev Respir Dis 1990; 141: 
94-7. 
6. Sriskandan S, Cohen J. The pathogenesis of septic shock. 
J Infect 1995; 30: 201-6. 
7. Wenzel RP. The mortality of hospital-acquired blood stream 
infections: need for a new vital statistic. Int J Epidemiol 
8. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 
9. Wenzel Rp, Pinsky MR, Ulevitch RJ, Young L. Current 
understanding of sepsis. Clin Infect Dis 1996; 22: 407-13. 
10. Bone RC. Inhibitors of complement and neutrophils: a 
critical evaluation of their role in the treatment of sepsis. Crit 
Care Med 1992; 2 0  891-8. 
11. Bone RC. Phospholipids and their inhibitors: a critical 
evaluation of their role in the treatment of sepsis. Crit Care 
Med 1992; 2 0  884-90. 
12. Lynn WA, Cohen J. Management of septic shock. J Infect 
13. Schumann RR, Leong SR, Flaggs GW, et al. Structure and 
function of lipopolysaccharide binding protein. Science 
14. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison 
JC. CD14, a receptor for complexes of lipopolysaccharide 
(LPS) and LPS-binding protein. Science 1990; 249: 1431-3. 
15. Pugin J. Recogmtion of bacteria and bacterial products by 
host immune cells in sepsis. In Vincent J-L, ed. Yearbook of 
1988; 17: 225-7. 
1989; 320: 365-76. 
1995; 30: 207-12. 
1990; 249: 1429-31. 
intensive care and emergency memcine. London: Springer- 
Verlag; 1996: 11-23. 
16. Tobias PS, Mathison J, Mintz D, et al. Participation of 
lipopolysaccharide-binding protein in lipopolysaccharide- 
dependent macrophage activation. Am J Respir Cell Mol 
Biol 1992; 7: 239-45. 
17. Lynn WA, Cohen J. Adjunctive therapy for septic shock: a 
review of experimental approaches to therapy. Clin Infect 
Dis 1995; 20: 143-58. 
18. Tracey KJ. TNF and Mae West or: death f?om too much of 
a good thing. Lancet 1995; 345: 75-6. 
19. Cerami A, Beutler B. The role of cachectin/TNF in endo- 
toxic shock and cachexia. Immunol Today 1988; 9: 28-31. 
20. Michie HR, Manogue KR, Spriggs DR, et al. Detection of 
circulating tumor necrosis factor after endotoxin adrmnistra- 
tion. N Engl J Med 1988; 318: 1481-6. 
21. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl 
J Med 1993; 328: 1471-7. 
22. Schlievert PM. Role of superantigens in human disease. 
J Infect Dis 1993; 167: 997-1002. 
23. Webb SR, Gascoigne NR. T-cell activation by super- 
antigens. Curr Opin Immunol 1994; 6: 467-75. 
24. Hurley JC. Antibiotic-induced release of endotoxin. A 
therapeutic paradox. Drug Safety 1995; 12: 183-95. 
25. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment 
for sepsis: A critical appraisal and meta-analysis of the 
literature. Crit Care Med 1995; 23: 1430-9. 
26. Lefering R, Neugebauer EAM. Steroid controversy in sepsis 
and septic shock a meta-analysis. Crit Care Med 1995; 23: 
1294-303. 
